Swiss National Bank’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $592K | Hold |
|
|||||
|
2024
Q3 | $1.01M | Hold |
|
|||||
|
2024
Q2 | $500K | Hold |
|
|||||
|
2024
Q1 | $958K | Buy |
|
|||||
|
2023
Q4 | $1.45M | Sell |
|
|||||
|
2023
Q3 | $2.12M | Buy |
|
|||||
|
2023
Q2 | $4.62M | Buy |
|
|||||
|
2023
Q1 | $5.72M | Sell |
|
|||||
|
2022
Q4 | $3.62M | Buy |
|
|||||
|
2022
Q3 | $5.17M | Buy |
|
|||||
|
2022
Q2 | $2.23M | Hold |
|
|||||
|
2022
Q1 | $3.14M | Buy |
|
|||||
|
2021
Q4 | $2.44M | Hold |
|
|||||
|
2021
Q3 | $4.16M | Hold |
|
|||||
|
2021
Q2 | $4.43M | Buy |
|
|||||
|
2021
Q1 | $3.82M | Buy |
|
|||||
|
2020
Q4 | $3.8M | Buy |
|
|||||
|
2020
Q3 | $2.92M | Buy |
|
|||||
|
2020
Q2 | $2.79M | Buy |
|
|||||
|
2020
Q1 | $1.33M | Buy |
|
|||||
|
2019
Q4 | $1.44M | Buy |
|
|||||
|
2019
Q3 | $954K | Hold |
|
|||||
|
2019
Q2 | $951K | Buy |
|
|||||
|
2019
Q1 | $1.09M | Buy |
|
|||||
|
2018
Q4 | $1.05M | Buy |
|
|||||
|
2018
Q3 | $1.27M | Hold |
|
|||||
|
2018
Q2 | $1.4M | Hold |
|
|||||
|
2018
Q1 | $1.57M | Sell |
|
|||||
|
2017
Q4 | $1.85M | Buy |
|
|||||
|
2017
Q3 | $977K | Buy |
|
|||||
|
2017
Q2 | $867K | Hold |
|
|||||
|
2017
Q1 | $683K | Buy |
|
|||||
|
2016
Q4 | $637K | Hold |
|
|||||
|
2016
Q3 | $498K | Hold |
|
|||||
|
2016
Q2 | $418K | Hold |
|
|||||
|
2016
Q1 | $518K | Buy |
|
|||||
|
2015
Q4 | $845K | Buy |
|
|||||
|
2015
Q3 | $620K | Buy |
|
|||||
|
2015
Q2 | $622K | Buy |
|
|||||
|
2015
Q1 | $268K | Hold |
|
|||||
|
2014
Q4 | $219K | Buy |
|
|||||
|
2014
Q3 | $204K | Hold |
|
|||||
|
2014
Q2 | $359K | Buy |
|